Siemens acquires magnet maker
Oxford Magnet Technology will become a wholly owned subsidiary of Siemens Medical Systems late next year. Siemens, which holds a 51% stake in the British company, plans to purchase the remaining shares in a deal valued at $15.5 million, according to a
Oxford Magnet Technology will become a wholly owned subsidiary of Siemens Medical Systems late next year. Siemens, which holds a 51% stake in the British company, plans to purchase the remaining shares in a deal valued at $15.5 million, according to a Nov. 11 company announcement. Siemens will exercise its right to the buyout under a 1989 joint venture agreement with Oxford Instruments. The buyout is expected to occur when the initial 15-year term of the joint venture ends in September 2004. The transaction includes cash and the ongoing use by Oxford Instruments of certain intellectual property. It is subject to formal regulatory approval under German competition law. Oxford Magnet Technology was founded in 1982 to commercialize proprietary technology for MR magnets and accessories.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.
